Acciones Isodiol International Inc Canadian Securities Exchange
Acciones
CA46500L1013
Farmacéuticos
Ventas 2018 | 19,14 M 26,18 M 17,78 M | Ventas 2019 | 22,25 M 30,43 M 20,68 M | Capitalización | 49,96 M 68,33 M 46,43 M |
---|---|---|---|---|---|
Resultado Neto 2018 | -36 M -49,24 M -33,46 M | Resultado Neto 2019 | -126 M -172 M -117 M | VE / Ventas 2018 | 12,6 x |
Posición de caja neta 2018 | 15,55 M 21,27 M 14,45 M | Deuda neta 2019 | 5,22 M 7,14 M 4,85 M | VE / Ventas 2019 | 2,48 x |
P/E ratio 2018 |
-4,94
x | P/E ratio 2019 |
-0,37
x | Empleados | - |
Rendimiento 2018 * |
-
| Rendimiento 2019 |
-
| Flotante | 100 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 14/02/19 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Director/Board Member | - | 21/11/18 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+26,93 % | 5547,48 M | |
-33,55 % | 3524,46 M | |
-3,74 % | 3029,31 M | |
-26,09 % | 2586,23 M | |
-10,93 % | 2283,89 M | |
+41,50 % | 1878,77 M | |
+41,84 % | 1459,35 M | |
-12,94 % | 1428,5 M | |
+47,62 % | 1422,11 M |